We invite you to read the report prepared by HTA Consulting, which aims to present systemic consequences related to the introduction of a new model of access to innovative drugs in Poland in the light of the Medical Fund Act.
Due to the Act on the Medical Fund in force we looked into registration drugs in European Medicines Agency (EMA) to see which products may be included in the upcoming high clinical value drugs list by AOTMiT. From 2017 to the end of July 2021, 268 new
We invite you to read the report "Every day counts", published by EFPIA, supported by the CEESTAHC association. Magdalena Władysiuk, vice president of HTA Consulting, was a participant of the Sounding Board. The report addresses the issue of access to innovative therapies in oncology and